DocDollars

Emergent Biosolutions Inc.

MD · United States · Reporting entity ID 100000011074

Total reported 2019–2025
$72.8M
#129 of 2,960 reporting companies — 0.1% of all reported industry payments
$1.84M in general payments across 1,625 records, plus $71.0M in research funding across 36,425 records.

How it breaks down

General payments $1,835,057
Research funding $71,014,766

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Emergent Biosolutions Inc. reported $72.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #129 of 2,960 reporting companies. 97% of that was research funding and 3% general payments such as consulting, speaking, food and travel. 1,625 general payment records and 36,425 research records were filed.

Common questions about Emergent Biosolutions Inc.

How much has Emergent Biosolutions Inc. paid US doctors?

Emergent Biosolutions Inc. reported $72,849,824 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,835,057 in general payments, $71,014,766 in research funding.

How does Emergent Biosolutions Inc. rank among drug and device companies?

It ranks #129 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Emergent Biosolutions Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.